Wearable Devices in the Medical Sector

Tuesday, June 7, 2016 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 7, 2016 /PRNewswire/ --

http://www.FinancialBuzz.com: Wearable devices is an enormous market with

constant advancement in technologies. A market research by IDTechEx Research shows how the wearable devices market was segmented in 2015. The largest segment, Advanced Infotainment, which mostly includes all the smart watches from Apple, and Samsung
that sync with smartphones and tablets. The second largest segment is the one with long term prospects and technological potential, the Health, Medical, Fitness and Wellness segment. Biotricity Inc. (OTC: BTCY), Koninklijke Philips NV (NYSE: PHG), Medtronic PLC (NYSE: MDT), Fitbit Inc. (NYSE: FIT), Apple Inc. (NASDAQ: AAPL)

A recent report by Frost & Sullivan, a consulting firm which provides market research and analysis, claims that the global healthcare wearable devices market earned revenues of $5.1 billion in 2015 and estimates revenues to reach $18.9 billion in 2020. This suggests a growth of 270% in 5 years. The report further elaborates that new technology will provide commercialized solutions, drive up demand, and wearables in the medical segment dedicated to chronic disease monitoring and other clinical purposes can transform care provision models.

While most companies try to appeal to various segments of the wearable devices markets, some made transforming healthcare industry to help physicians better monitor patients their goal. A little known company Biotricity Inc. (OTCQB: BTCY) is focusing on biometric monitoring solutions for medical, healthcare and consumer use. The company has two devices that will launch into the market this year, Bioflux and Biolife.

Bioflux includes an ECG (heart-rhythm) monitoring device, software and access to a monitoring lab. The software component is already FDA approved and a standard for ECG monitoring in hospitals and cardiac clinics. Bioflux is by all means, a medical wearable device, and is only available with a prescription. It performs remote MCT diagnostic monitoring for up to 30 consecutive days and is a solution that enables physicians to diagnose Cardiovascular Disease (CVD) or Coronary Heart Disease (CHD).

Biolife is a much more easily accessible device. It is designed to provide health and lifestyle solutions by monitoring ECG, respiration rate, calories, temperature, physical activity and more. The product is currently in development stages and will be ready to hit the market in the near future. Essentially, Biolife is a medical device designed to facilitate disease management, example Cardiovascular monitoring.

Biotricity recently announced the company has appointed Thomas Nelson and J. Bernard Rice to its newly formed Board of Advisors (BOA). "As we continue to look to the future of Biotricity, it's extremely important that the company receives timely insight and knowledge from industry experts who know and understand our business and what benefits both consumers and the medical community…", stated Waqaas Al-Siddiq, founder, president and CEO of Biotricity.

Companies like Koninklijke Philips NV (NYSE: PHG) and Medtronic PLC (NYSE: MDT) have been the medical devices business for decades, and it was only a matter of time until they capitalize on wearable devices. Back in 2014 Medtronic acquired Corventis, which made noninvasive cardiac sensors. Medtronic then announced its first medical wearable device, the Seeq Mobile Cardiac Telemetry (MCT) System.

Then there is Fitbit (NASDAQ: FIT). The company's CEO, James Park, focused heavily on the potential in the medical device segment after the recent earnings report. "We are learning that lack of consumer engagement is a critical missing element in many broad healthcare efforts such as population health and disease management," he said, "…Since our devices and services are already engaging, Fitbit has incredible opportunity to serve as the consumer healthcare engagement engine."

 Playing a wider role in medical wearable devices is becoming a main priority. Despite the impressive growth expectations for this segment, there are some challenges companies will have to deal with in the near term, like high costs and lack of insurance policies. These challenges however are expected to be resolve overtime and are normal to new technologies in the medical field.

For "The Latest Buzz in Financial News", Please Visit: http://www.FinancialBuzz.com

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has signed a three month financial news pr services agreement for fifteen thousand dollars directly from biotricity inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting the high quality and sophisticated content on this site along with other financial news pr media services.  Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof.  The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com agreed to a three month financial news pr services agreement for fifteen thousand restricted shares directly from the company and additional same amount at the end of the term. We do not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security.  FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print.  Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

Media Contact: Danny A. info@financialbuzz.com +1-877-601-1879

SOURCE FinancialBuzz.com.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store